As the age of antibiotics falters under the weight of resistance, a team at Hebrew University of Jerusalem has uncovered a molecular secret hidden for seventy-five years inside one of science's most studied viruses. The discovery of PreS — an RNA switch that enables bacteriophages to commandeer and destroy bacterial cells from within — offers a new foothold in humanity's oldest struggle against infection. With over a million lives lost annually to resistant bacteria, this quiet breakthrough in molecular listening may help restore what modern medicine has slowly been losing.
The Times of Israel
· Dec 19, 2025
· health
· 3 min read
High
Sourcing: Verified
Hebrew University scientists discover RNA 'switch' that could unlock phage therapy against superbugs
Antibiotic-resistant bacteria directly caused 1.27 million deaths globally in 2019, with approximately 5,000 Israelis dying annually from resistant infections.
◉
Education
1694 related articles
DOJ Investigates Duke Law's Race-Based Admissions Practices Post-SCOTU…
Fox News · 100% match
Low CLAT Score? Here's Your Roadmap to Law School Through Alternate Ex…
The Indian Express · 99% match
Brown professor exposes 40-student AI cheating scandal, criticizes uni…
Fox News · 99% match
Diet Quality Trumps Processing Level in New Health Study
Genetic Literacy Project · 90% match
Fox News Campus Radicals Newsletter highlights education policy disput…
Fox News · 90% match
Related Coverage
Capture Magazine · Sep 09
Sony launches first standalone E-mount fisheye lens with 8-14mm range
Sony introduced the FE 8-14mm F3.5 Fisheye G, its first standalone fisheye lens for full-frame E-mount cameras, offering…
BBC News · Sep 09 Tung Chee-hwa, Hong Kong's First Post-Handover Leader, Dies at 89Tung Chee-hwa, Hong Kong's first leader after the 1997 British handover, has died at 89. His tenure was marked by financ…
The Guardian · Sep 09 Maternal anaemia linked to smaller brains in infants, study warnsA study of over 300 mothers in Cape Town found babies born to anaemic mothers have 4% smaller brains, particularly in re…
Associated Press · Sep 09 SEC leaders weigh LSU expulsion over pro player roster violationsSEC leaders are discussing expelling LSU after the university attempted to roster professional players, violating NCAA r…
Bias & Framing
⚖
Article presents scientific discovery with institutional pride framing; minimal bias detected in reporting of research findings and global health context.
Bias Direction
center
Confidence
MED
Institutional achievement narrative combined with global health crisis framing to establish urgency and relevance of the research
unlock
war against superbugs
defy antibiotics
global health threat
Skeptical scientific voices or limitations of phage therapy
Timeline and realistic expectations for clinical applications
Perspectives from pharmaceutical industry or competing research approaches
Patient or public health official commentary on phage therapy potential
Geopolitical Impact
🌎
Hebrew University's discovery of PreS RNA molecule advances phage therapy against antibiotic-resistant bacteria, potentially reshaping global antimicrobial treatment strategies and reducing dependence on conventional antibiotics.
Escalation Risk
low
Confidence
HIGH
Global
Israel
United States
European Union
Developing nations with high antimicrobial resistance burden
Scientific leadership in biotechnology shifts toward institutions pioneering alternative therapies; Israel-US research collaboration strengthens; nations with advanced biotech sectors gain competitive advantage in addressing global health crises; potential reduction in pharmaceutical industry's antibiotic monopoly.
Similar to the penicillin discovery (1928) that revolutionized medicine and shifted global health paradigms; represents a return to phage therapy research abandoned after antibiotics' rise, now necessitated by resistance crisis.
Economic Lens
📈
Hebrew University discovery of PreS RNA molecule enables bacteriophage therapy against antibiotic-resistant bacteria, potentially creating new biotech market opportunities as antimicrobial resistance costs global healthcare systems billions annually.
Market Signal
bullish
Confidence
MED
Biotechnology and pharmaceutical manufacturing
Healthcare and hospital services
Medical research and development
Diagnostic testing services
Agricultural antibiotics market (potential substitution)
Consumers facing antibiotic-resistant infections could gain access to alternative treatments, potentially reducing hospitalization costs and mortality rates. Long-term healthcare expenses may decrease as phage therapy becomes commercialized, though initial adoption costs may be high.
Governments may accelerate regulatory pathways for phage therapy approval (FDA, EMA). Increased R&D funding for alternative antimicrobial solutions likely. Potential restrictions on agricultural antibiotic use to preserve effectiveness. International coordination on antimicrobial stewardship programs expected to intensify.